4.2 Article

HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Identification of a novel replication-competent hepatitis C virus variant that confers the sofosbuvir resistance

Steve Leumi et al.

Summary: Despite the excellent antiviral potency of direct-acting antivirals (DAAs) against hepatitis C virus (HCV), drug-resistant viral mutations remain a potential challenge. This study identified the combination of two NS5B mutations, S282T and K74R, as a novel resistance-associated substitution (RAS) that confers substantial resistance to SOF while retaining the HCV replication capacity.

ANTIVIRAL RESEARCH (2022)

Article Gastroenterology & Hepatology

Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

Chen-Hua Liu et al.

Summary: In patients with severe renal impairment and chronic hepatitis C virus infection, sofosbuvir/velpatasvir (SOF/VEL) with or without low-dose ribavirin (RBV) for 12 weeks showed high effectiveness and safety, with high sustained virological response rates and minimal adverse events.
Review Immunology

Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice

Mehran Ghasemzadeh et al.

Summary: The COVID-19 virus disrupts immune responses by interfering with the cytolytic antiviral effects of NK cells and activating immune cells, leading to a dangerous cytokine storm. Improving the cytotoxicity of NK cells may benefit treatment protocols, and the clonal expansion of activating NK memory cells holds promise for vaccine development and NK cell therapy in COVID-19.

HUMAN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV

Giulia Morsica et al.

Summary: This study retrospectively evaluated the dynamics of HIV viral load in HIV/HCV patients treated with direct acting antivirals (DAAs). The results showed that the presence of baseline HIV residual viremia, previous virological blips, the number of failed ART regimens before DAAs initiation, and age were significantly associated with HIV virological failure.

PLOS ONE (2022)

Review Infectious Diseases

Antivirals against HCV infection: the story thus far

Ahmad Adebayo Irekeola et al.

Summary: Remarkable scientific breakthroughs have been made in the development of anti-HCV regimens, leading to the transition from interferon-based treatments to all-oral interferon-free regimens. Despite some drugs still under development, several have been approved and shown high sustained virologic response rates of > 90%. However, achieving the WHO global target of eliminating hepatitis C as a public health problem by 2030 remains uncertain.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2022)

Article Multidisciplinary Sciences

HIV-reservoir size is not affected either by HCV coinfection or by direct acting antivirals (DAAs) therapy

Beatriz Alvarez et al.

Summary: This study assessed the impact of HCV eradication on HIV-DNA content in HIV/HCV-coinfected patients treated with direct-acting antivirals. The results suggest that HCV does not influence the size of the HIV reservoir and that DAAs do not have an anti-HIV action.

SCIENTIFIC REPORTS (2022)

Article Microbiology

Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt

Aly Atef Shoun et al.

Summary: This study investigated the genotype and structural analysis of patients with genotype 4a hepatitis C virus (HCV) infections who failed to respond to sofosbuvir treatment. The presence of mutation sites and amino acid substitutions associated with resistance to sofosbuvir was identified. The results highlight the significant impact of these mutations on the resistance of the HCV NS5B RNA-dependent RNA polymerase to direct-acting antivirals.

MICROORGANISMS (2022)

Article Immunology

HLA-E gene polymorphisms in chronic hepatitis C: Impact on HLA-E liver expression and disease severity

Roberta Chaves Araujo et al.

Summary: The study investigated the impact of HLA-E gene polymorphisms on HLA-E liver expression and severity of hepatitis C, revealing associations between specific HLA-E variations and disease severity parameters, providing biological clues for understanding the mechanisms associated with hepatitis C.

HUMAN IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Treatment failure with DAA therapy: Importance of resistance

Christoph Sarrazin

Summary: Viral resistance is a major factor in virological failure of patients with chronic HCV infection receiving DAAs treatment, with the importance varying based on DAA regimen and HCV genotype. First-line therapy with G/P or VEL/SOF may not require baseline resistance analysis, while VOX/VEL/SOF is the preferred second-line treatment option. Different patient subgroups may benefit from resistance testing to optimize therapy.

JOURNAL OF HEPATOLOGY (2021)

Article Microbiology

Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis

Hannes Vietzen et al.

Summary: The study reveals the complex interaction between human cytomegalovirus (HCMV) and host immune responses, particularly the interaction between HLA-E and the virus-encoded UL40 peptide, leading to a potent NK cell response and reduction in virus replication in immunosuppressed patients. Different naturally occurring HCMV-UL40 variants reduce the activation of specific host NK cells subpopulation and are associated with high-level viremia in patients, highlighting the importance of understanding these interactions in the development of severe HCMV infection and vaccine strategies.
Review Biochemistry & Molecular Biology

Dimorphism of HLA-E and Its Disease Association

Leonid Kanevskiy et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pharmacology & Pharmacy

Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection

Ulrich Spengler

PHARMACOLOGY & THERAPEUTICS (2018)

Article Immunology

Identification of novel HIV-1-derived HLA-E-binding peptides

Zara Hannoun et al.

IMMUNOLOGY LETTERS (2018)

Article Immunology

HLA-E Peptide Repertoire and Dimorphism-Centerpieces in the Adaptive NK Cell Puzzle?

Alexander Roelle et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Immunology

HLA-E polymorphisms in an Afro-descendant Southern Brazilian population

Luana Carvalho dos Santos et al.

HUMAN IMMUNOLOGY (2013)

Review Immunology

Clinical Significance of the HLA-E and CD94/NKG2 Interaction

Milena Iwaszko et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)

Review Biotechnology & Applied Microbiology

The Emerging Role of HLA-E-Restricted CD8(+) T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors

Gabriella Pietra et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Article Rheumatology

HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia

Fabiana Paladini et al.

ARTHRITIS RESEARCH & THERAPY (2009)

Article Cell Biology

HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease

K. S. Park et al.

TISSUE ANTIGENS (2007)

Article Cell Biology

HLA-E and immunobiology of pregnancy

P Tripathi et al.

TISSUE ANTIGENS (2006)

Review Immunology

MHC class IB molecules bridge innate and acquired immunity

JR Rodgers et al.

NATURE REVIEWS IMMUNOLOGY (2005)

Review Cell Biology

Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis

A Ahmad et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2004)

Article Cell Biology

Natural killer cells inhibit hepatitis C virus expression

Y Li et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2004)

Article Cell Biology

HLA-E polymorphism in patients with nasopharyngeal carcinoma

N Hirankarn et al.

TISSUE ANTIGENS (2004)

Article Multidisciplinary Sciences

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

G Pietra et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Immunology

Natural killer cells and their receptors

D Middleton et al.

TRANSPLANT IMMUNOLOGY (2002)

Article Immunology

Polymorphism of human leukocyte antigen-E gene in the Japanese population with or without recurrent abortion

T Kanai et al.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2001)